相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Breast Cancer Risk in Female Survivors of Hodgkin's Lymphoma: Lower Risk After Smaller Radiation Volumes
Marie L. De Bruin et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma
David C. Hodgson et al.
CANCER (2007)
Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease
Christophe Ferme et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Randomized comparison of consolidation radiation versus observation in bulky Hodgkin's lymphoma with post-chemotherapy negative positron emission tomography scans
Marco Picardi et al.
LEUKEMIA & LYMPHOMA (2007)
Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma:: Final results of the GHSG HD7 trial
Andreas Engert et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk
Eng-Siew Koh et al.
RADIATION ONCOLOGY (2007)
Second malignancy risk associated with treatment of Hodgkin's lymphoma:: meta-analysis of the randomised trials
J. Franklin et al.
ANNALS OF ONCOLOGY (2006)
Treatment-related premature ovarian failure as a long-term complication after Hodgkin's lymphoma
U. K. H. Haukvik et al.
ANNALS OF ONCOLOGY (2006)
Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma:: Long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials
Evert M. Noordijk et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma
M Hutchings et al.
BLOOD (2006)
Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors
DA Hill et al.
BLOOD (2005)
Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma
LB Travis et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group
RM Meyer et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: Long-term results
G Bonadonna et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma:: Results of the HD8 trial of the German Hodgkin's Lymphoma Study Group
A Engert et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Long-term cause-specific mortality of patients treated for Hodgkin's disease
BMP Aleman et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease
FE van Leeuwen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: Report of an intergroup trial
DB Duggan et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors
AK Ng et al.
BLOOD (2002)
Second malignant neoplasms among long-term survivors of Hodgkin's disease: A population-based evaluation over 25 years
GM Dores et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
分享论文
